Dose response to paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model

Investigative Radiology

Volumn 46, Issue 4, 2011, Pages 255-263

  Kelsch, Bettina ^a   Scheller, Bruno ^b   Biedermann, Melanie ^a   Clever, Yvonne P ^b   Schaffner, Silvio ^c   Mahnkopf, Dirk ^d   Speck, Ulrich ^a   Cremers, Bodo ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c Invatec Technology Center   (Switzerland)

^d IMTR GmbH   (Germany)

Author keywords

angioplasty; drug coated balloon catheters; paclitaxel; restenosis

Indexed keywords

IOPROMIDE; PACLITAXEL; UREA;

ANGIOCARDIOGRAPHY; ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; BLOOD; BLOOD VESSEL WALL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MALE; MORPHOMETRICS; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; SWINE; VITAL SIGN;

EID: 79952443081     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e31820577df     Document Type: Article

References (27)

1. Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med. 2006;354:483-495. (Pubitemid 43200299)
2. Gray BH, Conte MS, Dake MD, et al. Atherosclerotic peripheral vascular disease Symposium II. Lower-extremity revascularization: state of the art. Circulation. 2008;118:2864-2872.
3. Zeller T. Current state of endovascular treatment of femoropopliteal artery disease. Vasc Med. 2007;12:223-234. (Pubitemid 350055159)
4. de Graaf FR, Schuijf JD, van Velzen JE, et al. Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography to noninvasively assess in-stent restenosis. Invest Radiol. 2010;45:331-340.
5. Goetti R, Leschka S, Baumuller S, et al. Low dose high-pitch spiral acquisition 128-slice dual-source computed tomography for the evaluation of coronary artery bypass graft patency. Invest Radiol. 2010;45:324-330.
6. Ishigami K, Uemura S, Morikawa Y, et al. Long-term follow-up of neointimal coverage of sirolimus-eluting stents: evaluation with optical coherence tomography. Circ J. 2009;73:2300-2307.
7. Kim JS, Kim JS, Kim TH, et al. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation. Circ J. 2010;74:320-326.
8. Waksman R, Pakala R. Drug-eluting balloon. The comeback kid? Circ Cardiovasc Interv. 2009;2:352-358.
9. Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating-a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810-814. (Pubitemid 39096008)
10. Scheller B, Speck U, Böhm M. Prevention of restenosis-is angioplasty the answer? Heart. 2007;93:539-541.
11. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355: 2113-2124. (Pubitemid 44749319)
12. Cremers B, Biedermann M, Mahnkopf D, et al. Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin Res Cardiol. 2009;98:325-330.
13. Speck U, Scheller B, Abramjuk C, et al. Neointimal inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology. 2006;240:411-418. (Pubitemid 44098636)
14. Albrecht T, Speck U, Baier C, et al. Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine. Invest Radiol. 2007;42:579-585. (Pubitemid 47051835)
15. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699. (Pubitemid 351240748)
16. Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation. 2009;119:2986-2994.
17. Cremers B, Speck U, Kaufels N, et al. Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost. 2009;101:201-206.
18. Cortese B, Micheli A, Picchi A, et al. Paclitaxel-Eluting Balloon Versus Paclitaxel-Eluting Stent in Small Coronary Vessel Disease. Barcelona, Spain: The Piccoleto Trial EuroPCR; 2009.
19. Posa A, Hemetsberger R, Petnehazy O, et al. Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries. Coron Artery Dis. 2008;19:243-247.
20. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol. 1992;19:267-274.
21. Kornowski R, Hong MK, Tio FO, et al. In-stent restenosis contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31:224-230. (Pubitemid 28064746)
22. Cremers B, Clever Y, Schaffner S, et al. Treatment of coronary in-stent restenosis with a novel paclitaxel-urea-coated balloon. Minerva Cardioangiol. 2010;58:583-588.
23. Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation. 2001;104:473-479. (Pubitemid 32678280)
24. Park SJ, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 2003;348:1537-1545. (Pubitemid 36437930)
25. Speck U, Scheller B, Abramjuk C, et al. Inhibition of restenosis in stented porcine coronary arteries: uptake of paclitaxel from angiographic contrast media. Invest Radiol. 2004;39:182-186. (Pubitemid 38263924)
26. Schwartz RS, Chronos NA, Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol. 2004;44:1373-1385. (Pubitemid 39303937)
27. Nakazawa G, Finn AV, John MC, et al. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents. Am J Cardiol. 2007;100:36M-44M.